Literature DB >> 31126855

Anticancer saponin OSW-1 is a novel class of selective Golgi stress inducer.

Mayu Kimura1, Kanae Sasaki2, Yosuke Fukutani1, Hiderou Yoshida2, Ikuroh Ohsawa3, Masafumi Yohda1, Kaori Sakurai4.   

Abstract

OSW-1 is a plant-derived natural product proposed to selectively kill cancer cells by binding to members of the oxysterol binding protein family, thereby disrupting lipid/sterol homeostasis. However, how these protein-ligand interactions mediate cell death signaling has remained elusive. Here, we discovered that OSW-1 selectively activates the Golgi stress response leading to apoptosis, providing a mechanistic basis for the anticancer activity of OSW-1.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticancer natural product; Golgi stress response; OSBP; OSW-1; Saponin

Year:  2019        PMID: 31126855     DOI: 10.1016/j.bmcl.2019.05.022

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.

Authors:  Mengling Wu; Qianrui Huang; Mengya Liao; Xuyi Wu; Huizhi Xi; Hongbo Ma; Shanrui Li; Yiwen Zhang; Yong Xia
Journal:  Cell Oncol (Dordr)       Date:  2022-09-26       Impact factor: 7.051

2.  Galtonosides A-E: Antiproliferative and Antiplasmodial Cholestane Glycosides from Galtonia regalis.

Authors:  Yongle Du; Brooke A Martin; Ana Lisa Valenciano; Jason A Clement; Michael Goetz; Maria B Cassera; David G I Kingston
Journal:  J Nat Prod       Date:  2020-03-31       Impact factor: 4.050

Review 3.  Saponins in Cancer Treatment: Current Progress and Future Prospects.

Authors:  Olusola Olalekan Elekofehinti; Opeyemi Iwaloye; Femi Olawale; Esther Opeyemi Ariyo
Journal:  Pathophysiology       Date:  2021-06-05

4.  Anticancer effects of OSW-1 on glioma cells via regulation of the PI3K/AKT signal pathway: A network pharmacology approach and experimental validation in vitro and in vivo.

Authors:  Zhixin Zhan; Ziqiang Liu; Chaochao Zhang; Haijun Gao; Jiacheng Lai; Yong Chen; Haiyan Huang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.